🟢 Moleculin Biotech is trading 6.19% up with no clear company-specific catalyst reported

Moleculin Biotech is trading 6.19% up at $0.64, with no clearly reported company-specific announcement on August 18, 2026 explaining the move.

• The August 14 earnings update highlighted continued MIRACLE-trial progress and a potential 2027 NDA filing; that news predates the current session.
• Broader markets are falling, so the gain does not appear driven by overall market sentiment.
• Recent trading activity has been elevated, suggesting continued speculative interest; the immediate catalyst remains unclear.